The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 21,390 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 3,945 | 2,087,312 | SH | SOLE | 2,087,312 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 31,949 | 1,966,100 | SH | SOLE | 1,966,100 | 0 | 0 | ||
ARCUS BIOSCIENCES INC | COM | 03969F109 | 7,372 | 729,905 | SH | SOLE | 729,905 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 32,444 | 202,117 | SH | SOLE | 202,117 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 55,022 | 1,339,069 | SH | SOLE | 1,339,069 | 0 | 0 | ||
ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 48,864 | 2,388,268 | SH | SOLE | 2,388,268 | 0 | 0 | ||
ATRECA INC | CL A COM | 04965G109 | 22,917 | 1,481,411 | SH | SOLE | 1,481,411 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 26,422 | 312,500 | SH | Call | SOLE | 312,500 | 0 | 0 | |
CHIASMA INC | COM | 16706W102 | 15,097 | 3,043,827 | SH | SOLE | 3,043,827 | 0 | 0 | ||
CORVUS PHARMACEUTICALS INC | COM | 221015100 | 4,013 | 737,612 | SH | SOLE | 737,612 | 0 | 0 | ||
CYCLERION THERAPEUTICS INC | COM | 23255M105 | 4,926 | 1,811,000 | SH | SOLE | 1,811,000 | 0 | 0 | ||
CYTOMX THERAPEUTICS INC | COM | 23284F105 | 3,407 | 410,000 | SH | SOLE | 410,000 | 0 | 0 | ||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 79,916 | 3,627,597 | SH | SOLE | 3,627,597 | 0 | 0 | ||
EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 6,695 | 449,338 | SH | SOLE | 449,338 | 0 | 0 | ||
EVOLUS INC | COM | 30052C107 | 7,302 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
EXICURE INC | COM | 30205M101 | 10,136 | 3,544,186 | SH | SOLE | 3,544,186 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 8,833 | 451,354 | SH | SOLE | 451,354 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 29,015 | 676,500 | SH | Call | SOLE | 676,500 | 0 | 0 | |
FIBROGEN INC | COM | 31572Q808 | 64,001 | 1,492,221 | SH | SOLE | 1,492,221 | 0 | 0 | ||
HARPOON THERAPEUTICS INC | COM | 41358P106 | 13,437 | 908,547 | SH | SOLE | 908,547 | 0 | 0 | ||
IGM BIOSCIENCES INC | COM | 449585108 | 3,816 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
INNATE PHARMA S A | SPONSORED ADS | 45781K204 | 29,273 | 4,545,454 | SH | SOLE | 4,545,454 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 5,914 | 213,647 | SH | SOLE | 213,647 | 0 | 0 | ||
IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 58,183 | 4,371,408 | SH | SOLE | 4,371,408 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 58,327 | 4,241,953 | SH | SOLE | 4,241,953 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 24,192 | 1,718,200 | SH | SOLE | 1,718,200 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 8,376 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
MORPHIC HLDG INC | COM | 61775R105 | 36,977 | 2,154,845 | SH | SOLE | 2,154,845 | 0 | 0 | ||
NEOLEUKIN THERAPEUTICS INC | COM | 64049K104 | 48,244 | 3,915,880 | SH | SOLE | 3,915,880 | 0 | 0 | ||
PIERIS PHARMACEUTICALS INC | COM | 720795103 | 9,177 | 2,535,212 | SH | SOLE | 2,535,212 | 0 | 0 | ||
PREVAIL THERAPEUTICS INC | COM | 74140Y101 | 35,591 | 2,248,306 | SH | SOLE | 2,248,306 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 149,224 | 9,426,640 | SH | SOLE | 9,426,640 | 0 | 0 | ||
RUBIUS THERAPEUTICS INC | COM | 78116T103 | 4,996 | 525,877 | SH | SOLE | 525,877 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 12,515 | 173,364 | SH | SOLE | 173,364 | 0 | 0 | ||
SAVARA INC | COM | 805111101 | 6,418 | 1,432,664 | SH | SOLE | 1,432,664 | 0 | 0 | ||
SELECTA BIOSCIENCES INC | COM | 816212104 | 10,943 | 4,597,701 | SH | SOLE | 4,597,701 | 0 | 0 | ||
SURFACE ONCOLOGY INC | COM | 86877M209 | 2,447 | 1,301,713 | SH | SOLE | 1,301,713 | 0 | 0 | ||
TCR2 THERAPEUTICS INC | COM | 87808K106 | 3,420 | 239,500 | SH | SOLE | 239,500 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 11,171 | 261,554 | SH | SOLE | 261,554 | 0 | 0 | ||
UROVANT SCIENCES LTD | SHS | G9381B108 | 411 | 26,468 | SH | SOLE | 26,468 | 0 | 0 | ||
VERICEL CORP | COM | 92346J108 | 2,279 | 131,001 | SH | SOLE | 131,001 | 0 | 0 | ||
X4 PHARMACEUTICALS INC | COM | 98420X103 | 4,445 | 415,400 | SH | SOLE | 415,400 | 0 | 0 | ||
XENCOR INC | COM | 98401F105 | 86,029 | 2,501,557 | SH | SOLE | 2,501,557 | 0 | 0 |